The financial markets are experiencing volatility, highlighted by a 211-point drop in the Dow Jones Industrial Average, as investors react to Federal Reserve discussions on interest rates. While Fed officials suggest a slowdown in rate hikes, the assurance of continued monetary tightening has prompted a 1.1% decline in the Nasdaq. Amidst this backdrop, Biogen's $5.6 billion acquisition of Apellis Pharmaceuticals aims to bolster its portfolio in immunology and rare diseases, despite mixed sentiment about long-term revenue potential. Additionally, hedge funds are raising stakes in major stocks like Occidental Petroleum as they navigate the challenges presented by rising interest rates, indicating a strategic shift in investment approaches within the sector.
Click a month on the chart to update the report below.
